Guidelines and Policy Statements
The field of non-invasive prenatal diagnosis is developing rapidly. For reference we are including a short list of guidelines below from leading institutions in the field of women’s healthcare.
American College of Obstetricians and Gynecologists (ACOG) Committee on Genetics
The Society for Maternal-Fetal Medicine (SMFM) Publications Committee
American College of Obstetricians and Gynecologists (ACOG)
- ACOG Guidelines Practice Bulletin: Guidelines and Policy Statements, Screening for Fetal Chromosomal Abnormalities, January 2007
International Society of Prenatal Diagnosis (ISPD)
- ISPD Rapid Response Statement: Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011
National Society of Genetic Counselors (NSGC)
The National Society of Genetic Counselors currently supports Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis (NIPT/NIPD) as an option for patients whose pregnancies are considered to be at an increased risk for certain chromosome abnormalities. NSGC urges that NIPT/NIPD only be offered in the context of informed consent, education, and counseling by a qualified provider, such as a certified genetic counselor. Patients whose NIPT/NIPD results are abnormal, or who have other factors suggestive of a chromosome abnormality, should receive genetic counseling and be given the option of standard confirmatory diagnostic testing. (Adopted 2012).
- NSGC’s NIPT White Paper: the position of the National Society of Genetic Counselors,
29 June 2012